CZO Ceapro Inc

Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or "the Company") announces today that
Mr. David Fielder, Ceapro's Chief Scientific Officer, is leaving the Company to
pursue other interests. Effective immediately, Dr. Paul Moquin will manage
Research and Development activities while other corporate functions previously
under Mr. Fielder's responsibilities will be directly assumed by the President
and CEO. 


"Dr. Moquin's background and expertise is in line with the current transitioning
of Ceapro towards other sectors like functional foods and nutraceuticals" said
Gilles Gagnon, President and CEO of Ceapro. "We wish to thank Mr. Fielder for
his long term contribution to Ceapro and we wish him all the best in his future
endeavors" he added.


About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business
activities relate to the development and commercialization of active ingredients
for personal care and cosmetic industries using proprietary technology and
natural, renewable resources. To learn more about Ceapro, visit www.ceapro.com. 


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Ceapro Inc.
Gilles Gagnon
President & CEO
Telephone (Edmonton): 780.421.4555
ggagnon@ceapro.com
www.ceapro.com

Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024

Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024